# Melanole, a Dietary Supplement, for the Treatment of Gastroesophageal Reflux Disease

> **NCT02587910** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Lebanese American University** · enrollment: 170 (estimated)

## Conditions studied

- GERD

## Interventions

- **DIETARY_SUPPLEMENT:** Melanole for GERD treatment
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02587910
- **Lead sponsor:** Lebanese American University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2016-04
- **Final completion:** 2016-09
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2015-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02587910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02587910, "Melanole, a Dietary Supplement, for the Treatment of Gastroesophageal Reflux Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02587910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*